Beyond HIV: Immuno-Engineering as a New Therapeutic Paradigm for Chronic Infectious and Oncological Diseases — Scientific Legacy and Translational Perspectives
| dc.contributor.author | Barack Ndenga | |
| dc.date.accessioned | 2026-01-19T11:01:48Z | |
| dc.date.issued | 2026-01-18 | |
| dc.description | This final article of the Frontières Thérapeutiques series posits that the global quest for an HIV cure has fundamentally reshaped medicine. I argue that the intense focus on combating this persistent virus has not merely produced specific technologies, but has catalyzed the emergence of a new therapeutic paradigm: immuno-engineering. This review traces how conceptual frameworks developed for HIV—confronting latency, immune exhaustion, and systemic complexity—have yielded a generalizable blueprint. I demonstrate how tools like CAR-T cells, gene editing, and therapeutic vaccines are migrating beyond virology to redefine the treatment of cancers and other chronic diseases. The article concludes that the true legacy of HIV research is the establishment of a programmable, systems-based approach to medicine, where the goal shifts from eradicating pathogens to architecting durable, engineered immunity. | |
| dc.description.abstract | The global effort to control and cure HIV has catalyzed some of the most transformative innovations in modern biomedicine. From gene-edited immune cells and engineered antibodies to programmable nanomedicine and systems-level therapeutic modeling, HIV research has evolved into a living laboratory for immuno-engineering. In this final article of the Frontières Thérapeutiques series, I explore how the conceptual and technological frameworks developed in the context of HIV transcend the virus itself. I argue that HIV cure research has laid the foundations for a new therapeutic paradigm, one in which diseases are addressed not merely by targeting pathogens or tumors, but by reprogramming immune systems as adaptive, engineered entities. This paradigm carries profound implications for chronic infectious diseases, oncology, and the future of precision medicine. Keywords : Immuno-engineering,HIV cure research,Therapeutic paradigm, Scientific legacy,Translational medicine,CAR-T cells,Gene editing,Therapeutic vaccines,Systems medicine,Programmable therapeutics,Oncology,Chronic infectious diseases,Precision medicine, Immune reprogramming,Biomedical innovation | |
| dc.description.provenance | Submitted by Barack Ndenga (ndengabarack@gmail.com) on 2026-01-18T23:22:00Z workflow start=Step: reviewstep - action:claimaction No. of bitstreams: 2 112th .pdf: 530498 bytes, checksum: d508ddb6cd61a8f34e2020a3619447bf (MD5) license_rdf: 1166 bytes, checksum: d700fae5b268849d8bbda3dffdc09cde (MD5) | en |
| dc.description.provenance | Step: reviewstep - action:reviewaction Approved for entry into archive by Jo Havemann (jo@africarxiv.org) on 2026-01-19T11:01:48Z (GMT) | en |
| dc.description.provenance | Made available in DSpace on 2026-01-19T11:01:48Z (GMT). No. of bitstreams: 2 112th .pdf: 530498 bytes, checksum: d508ddb6cd61a8f34e2020a3619447bf (MD5) license_rdf: 1166 bytes, checksum: d700fae5b268849d8bbda3dffdc09cde (MD5) Previous issue date: 2026-01-18 | en |
| dc.description.sponsorship | None | |
| dc.identifier.uri | https://africarxiv.ubuntunet.net/handle/1/10735 | |
| dc.language.iso | en | |
| dc.publisher | Publisher | |
| dc.rights | Attribution-NonCommercial-ShareAlike 3.0 United States | en |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/us/ | |
| dc.title | Beyond HIV: Immuno-Engineering as a New Therapeutic Paradigm for Chronic Infectious and Oncological Diseases — Scientific Legacy and Translational Perspectives | |
| dc.type | Article |
